v3.25.4
Fair Value Measurements and Financial Instruments - Summary of Fair Value Hierarchy (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Assets:    
Available for sale debt securities $ 18,800 $ 58,200
Equity securities 171,312 186,960
Available for sale debt securities 419,000 693,500
Liabilities:    
Cytokinetics Funding Commitments $ (9,100) $ (12,080)
Fair Value Asset Liability Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List Not Disclosed Flag fair value fair value
Fair Value, Recurring    
Assets:    
Total current assets $ 402,368 $ 626,517
Equity securities 171,312 186,960
Cytokinetics R&D Funding Derivative 0 12,000
Total non-current assets 590,312 897,783
Liabilities:    
Total non-current liabilities $ (9,100) $ (12,080)
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other assets Other assets
Royalty Investments | Fair Value, Recurring    
Assets:    
Royalty at fair value $ 0 $ 5,323
Cytokinetics Funding Commitment | Fair Value, Recurring    
Liabilities:    
Cytokinetics Funding Commitments (9,100) (12,080)
Available for sale debt securities    
Assets:    
Available for sale debt securities 18,800 58,200
Available for sale debt securities 419,000 693,500
Liabilities:    
Cytokinetics Funding Commitments 0 0
Available for sale debt securities | Fair Value, Recurring    
Assets:    
Available for sale debt securities 18,800 58,200
Available for sale debt securities 419,000 693,500
Money market funds | Fair Value, Recurring    
Assets:    
Money market funds 383,568 568,317
Level 1 | Fair Value, Recurring    
Assets:    
Total current assets 383,568 568,317
Equity securities 171,312 184,719
Cytokinetics R&D Funding Derivative 0 0
Total non-current assets 171,312 184,719
Liabilities:    
Total non-current liabilities 0 0
Level 1 | Royalty Investments | Fair Value, Recurring    
Assets:    
Royalty at fair value 0 0
Level 1 | Cytokinetics Funding Commitment | Fair Value, Recurring    
Liabilities:    
Cytokinetics Funding Commitments 0 0
Level 1 | Available for sale debt securities | Fair Value, Recurring    
Assets:    
Available for sale debt securities 0 0
Available for sale debt securities 0 0
Level 1 | Money market funds | Fair Value, Recurring    
Assets:    
Money market funds 383,568 568,317
Level 2 | Fair Value, Recurring    
Assets:    
Total current assets 0 0
Equity securities 0 0
Cytokinetics R&D Funding Derivative 0 0
Total non-current assets 0 0
Liabilities:    
Total non-current liabilities 0 0
Level 2 | Royalty Investments | Fair Value, Recurring    
Assets:    
Royalty at fair value 0 0
Level 2 | Cytokinetics Funding Commitment | Fair Value, Recurring    
Liabilities:    
Cytokinetics Funding Commitments 0 0
Level 2 | Available for sale debt securities | Fair Value, Recurring    
Assets:    
Available for sale debt securities 0 0
Available for sale debt securities 0 0
Level 2 | Money market funds | Fair Value, Recurring    
Assets:    
Money market funds 0 0
Level 3 | Fair Value, Recurring    
Assets:    
Total current assets 18,800 58,200
Equity securities 0 2,241
Cytokinetics R&D Funding Derivative 0 12,000
Total non-current assets 419,000 713,064
Liabilities:    
Total non-current liabilities (9,100) (12,080)
Level 3 | Royalty Investments | Fair Value, Recurring    
Assets:    
Royalty at fair value 0 5,323
Level 3 | Cytokinetics Funding Commitment | Fair Value, Recurring    
Liabilities:    
Cytokinetics Funding Commitments (9,100) (12,080)
Level 3 | Available for sale debt securities | Fair Value, Recurring    
Assets:    
Available for sale debt securities 18,800 58,200
Available for sale debt securities 419,000 693,500
Level 3 | Money market funds | Fair Value, Recurring    
Assets:    
Money market funds $ 0 $ 0